Several studies have shown that lipid exposure results in NLRP3 inflammasome-mediated hepatic inflammation and glucose dysregulation in a high-fructose-induced NAFLD mouse model. Here, NLRP3 is linked to metabolic dysfunction-associated steatotic liver disease.